[go: up one dir, main page]

NO20084072L - Ruthenium (II) sammensetninger - Google Patents

Ruthenium (II) sammensetninger

Info

Publication number
NO20084072L
NO20084072L NO20084072A NO20084072A NO20084072L NO 20084072 L NO20084072 L NO 20084072L NO 20084072 A NO20084072 A NO 20084072A NO 20084072 A NO20084072 A NO 20084072A NO 20084072 L NO20084072 L NO 20084072L
Authority
NO
Norway
Prior art keywords
nitrogen
ruthenium
bond
atom
ring
Prior art date
Application number
NO20084072A
Other languages
English (en)
Inventor
Peter John Sadler
Sarah Dougan
Abraha Habtermariam
Michel Melchart
Original Assignee
Univ Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Edinburgh filed Critical Univ Edinburgh
Publication of NO20084072L publication Critical patent/NO20084072L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046Ruthenium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

En ruthenium (Il) forbindelse med formel (I) hvor X er halo eller en nøytral eller negativt ladet O, N eller S donorligand; Y er et motion; m er 0 eller l; Q er 1, 2 eller 3; A er enten: (i) (Ru)-NRN1RN2-RN3-(N), hvor RN1 og RN2 er uavhengig valgt fra H, valgfritt substituert C1-7 alkyl, C3-20 heterosyklyl og C5-20 aryl, og RN3 er Cl-2 alkylen; eller (ii) en nitrogeninneholdende C5-6 aromatisk ring hvor nitrogenringatomet er bundet til rutheniumatomet og ringen er også bundet til azo-nitrogenet enten ved en enkel binding hvor bindingen er a eller ß for nitrogenringatomet, eller ved en -CH2-gruppe hvor bindingen er a for nitrogenringatomet; B er valgfritt substituert C1-7 alkyl, C3-20 heterosyklyl eller C5-20 aryl.
NO20084072A 2006-03-07 2008-09-24 Ruthenium (II) sammensetninger NO20084072L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0604602.3A GB0604602D0 (en) 2006-03-07 2006-03-07 Ruthenium (II) compounds
PCT/GB2007/000784 WO2007101997A1 (en) 2006-03-07 2007-03-07 Ruthenium (ii) compounds

Publications (1)

Publication Number Publication Date
NO20084072L true NO20084072L (no) 2008-11-05

Family

ID=36241152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084072A NO20084072L (no) 2006-03-07 2008-09-24 Ruthenium (II) sammensetninger

Country Status (13)

Country Link
US (1) US20090318402A1 (no)
EP (1) EP1991556A1 (no)
JP (1) JP2009529028A (no)
KR (1) KR20090017477A (no)
CN (1) CN101437831A (no)
AU (1) AU2007222271A1 (no)
BR (1) BRPI0708596A2 (no)
CA (1) CA2643685A1 (no)
GB (1) GB0604602D0 (no)
MX (1) MX2008011380A (no)
NO (1) NO20084072L (no)
WO (1) WO2007101997A1 (no)
ZA (1) ZA200807342B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2005512C2 (en) * 2010-10-14 2012-04-17 Univ Leiden Metal complex and use as multi-electron catalyst.
WO2013070988A2 (en) * 2011-11-09 2013-05-16 Niiki Pharma Inc. Method of treating osteosarcoma
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same
JP2018504428A (ja) * 2015-02-04 2018-02-15 ユーファーマ ピーティーワイ リミテッド ルテニウムおよびインジウム結合ガストリン
CN106478734B (zh) * 2016-10-18 2018-10-30 浙江大学 一种具有抗癌活性的吡唑官能团化的氮杂环卡宾钌化合物及其制备方法和应用
US10053480B1 (en) 2017-10-11 2018-08-21 King Saud University Anti-quorum and DNA cleaving agent
US10610280B1 (en) 2019-02-02 2020-04-07 Ayad K. M. Agha Surgical method and apparatus for destruction and removal of intraperitoneal, visceral, and subcutaneous fat
GB201903546D0 (en) * 2019-03-15 2019-05-01 Ldn Pharma Ltd Cancer treatment
CN114933622B (zh) * 2022-04-08 2023-01-20 安徽泽升科技有限公司 一种糖苷钌化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936624B2 (en) * 1991-04-27 2005-08-30 Nihon Bayer Agrochem K.K. Agents for preserving technical materials against insects
ATE303393T1 (de) * 1999-10-27 2005-09-15 Univ Court The University Of E Halbsandwich ruthenium(ii)-verbindungen mit einem stickstoff-haltigen liganden zur krebstherapie
GB0016052D0 (en) * 2000-06-30 2000-08-23 Univ Edinburgh Ruthenium (II) compounds
GB0215526D0 (en) * 2002-07-05 2002-08-14 Univ Edinburgh Anticancer compounds
MXPA05011653A (es) * 2003-04-30 2006-06-27 Univ Edinburgh Complejos de rutenio (ii) para el tratamiento de tumores.
GB0418613D0 (en) * 2004-08-20 2004-09-22 Pugh Rhoderick Internet security system

Also Published As

Publication number Publication date
US20090318402A1 (en) 2009-12-24
WO2007101997A1 (en) 2007-09-13
KR20090017477A (ko) 2009-02-18
CA2643685A1 (en) 2007-09-13
ZA200807342B (en) 2009-07-29
AU2007222271A1 (en) 2007-09-13
JP2009529028A (ja) 2009-08-13
EP1991556A1 (en) 2008-11-19
BRPI0708596A2 (pt) 2011-06-07
MX2008011380A (es) 2008-09-22
GB0604602D0 (en) 2006-04-19
CN101437831A (zh) 2009-05-20

Similar Documents

Publication Publication Date Title
NO20084072L (no) Ruthenium (II) sammensetninger
NO20074310L (no) Spiroketalderivat og anvendelse derav som diabetesmedisin
NO20052378L (no) Pre-organiserte trisykliske integraseinhibitorforbindelser
WO2009068531A3 (en) Adamantyl o-glucuronide derivatives as inhibitors of dipeptidyl peptidase iv for the treatment of diabetes
TW200643067A (en) Surface modifier
MX2009010909A (es) Derivados de ftalazino y su uso como medicamento para tratar el cancer.
NO20075809L (no) DNA-PK inhibitorer
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
NO20065578L (no) Substituerte metylaryl eller heteroarylamidforbindelser
WO2008081631A1 (ja) 重合性化合物及び重合性組成物
WO2009074749A3 (fr) Dérives de nicotinamide. leur préparation et leur application en thérapeutique
NO20081437L (no) Prepolymerer omfattende lavviskositetalkoksysilangrupper, fremgangsmate for fremstilling og anvendelse derav
WO2003106456A3 (en) Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity
EP1637521A4 (en) NEW TRICYCLIC HETEROCYCLIC COMPOUND
WO2008027812A3 (en) Imidazopyridine and imidazopyrimidine derivatives
MX2010004893A (es) Compuesto heterociclico y composicion farmaceutica del mismo.
SG144809A1 (en) Benzimidazole compounds and their use as chromatographic ligands
MX2009003927A (es) Derivado espirocetal de tioglucosa y uso del mismo como un agente terapeutico para la diabetes.
PT1603893E (pt) Antagonistas dos receptores ep4
MX2007005611A (es) Compuestos de imidazo[1,2-a]piridina, composiciones, usos y metodos relacionados.
NO20075904L (no) Benzimidazolforbindelser
UA101482C2 (ru) Способ получения 2'-дезокси-5-азацитидина (децитабина)
NO20080779L (no) Nye farmasoytiske forbindelser
WO2011061452A3 (fr) Précurseurs biscarbonates, leur procédé de préparation et leurs utilisations
WO2008147812A3 (en) 4' substituted compounds having 5-ht6 receptor affinity

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application